Klompas Neil A 4
4 · InMed Pharmaceuticals Inc. · Filed Oct 21, 2025
Insider Transaction Report
Form 4
Klompas Neil A
Director
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-10-17+3,500→ 3,500 totalExercise: $2.10Exp: 2030-10-16→ Common shares (3,500 underlying)
Footnotes (1)
- [F1](1) The options were granted on Oct 17, 2025 and will vest monthly, in arrears, as follows: (i) 98 stock options will vest on the 17th day of each month for 35 months, and (ii) 70 stock options will vest on Oct 17, 2025 (the three year anniversary of Grant date).